These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34113327)

  • 1. Mining of Gram-Negative Surface-Active Enzybiotic Candidates by Sequence-Based Calculation of Physicochemical Properties.
    Vázquez R; Blanco-Gañán S; Ruiz S; García P
    Front Microbiol; 2021; 12():660403. PubMed ID: 34113327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain.
    Vázquez R; Seoane-Blanco M; Rivero-Buceta V; Ruiz S; van Raaij MJ; García P
    Acta Crystallogr D Struct Biol; 2022 Apr; 78(Pt 4):435-454. PubMed ID: 35362467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal Delivery of Newly Identified Prophage Lysins in a
    Morais D; Tanoeiro L; Marques AT; Gonçalves T; Duarte A; Matos APA; Vital JS; Cruz MEM; Carvalheiro MC; Anes E; Vítor JMB; Gaspar MM; Vale FF
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077542
    [No Abstract]   [Full Text] [Related]  

  • 5. Beyond antibiotics: phage-encoded lysins against Gram-negative pathogens.
    Shah S; Das R; Chavan B; Bajpai U; Hanif S; Ahmed S
    Front Microbiol; 2023; 14():1170418. PubMed ID: 37789862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the Antibacterial Activity of Phage Lysin-Derived Peptide P87 through Maximization of Physicochemical Properties and Assessment of Its Therapeutic Potential.
    Vázquez R; Doménech-Sánchez A; Ruiz S; Sempere J; Yuste J; Albertí S; García P
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.
    Raz A; Serrano A; Hernandez A; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
    Heselpoth RD; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.
    Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L
    Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophages that infect Gram-negative bacteria as source of signal-arrest-release motif lysins.
    Gontijo MTP; Vidigal PMP; Lopez MES; Brocchi M
    Res Microbiol; 2021 Mar; 172(2):103794. PubMed ID: 33347948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered bacteriophage lysins as novel anti-infectives.
    Yang H; Yu J; Wei H
    Front Microbiol; 2014; 5():542. PubMed ID: 25360133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad Bactericidal Activity of the
    Antonova NP; Vasina DV; Lendel AM; Usachev EV; Makarov VV; Gintsburg AL; Tkachuk AP; Gushchin VA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30901901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel
    Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
    mSphere; 2017; 2(2):. PubMed ID: 28357414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins.
    Rotem S; Radzishevsky I; Inouye RT; Samore M; Mor A
    Peptides; 2006 Jan; 27(1):18-26. PubMed ID: 16165250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gram-Negative Bacterial Lysins.
    Ghose C; Euler CW
    Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32054067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage-derived endolysins to target gram-negative bacteria.
    Lai WCB; Chen X; Ho MKY; Xia J; Leung SSY
    Int J Pharm; 2020 Nov; 589():119833. PubMed ID: 32877733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Phage Lysin Abp013 against
    Chu JJK; Poh WH; Hasnuddin NTB; Hew EY; Dam LC; Sahili AE; Rice SA; Goh BC
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go.
    Gutiérrez D; Briers Y
    Curr Opin Biotechnol; 2021 Apr; 68():15-22. PubMed ID: 33053478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced engineering of third-generation lysins and formulation strategies for clinical applications.
    De Maesschalck V; Gutiérrez D; Paeshuyse J; Lavigne R; Briers Y
    Crit Rev Microbiol; 2020 Sep; 46(5):548-564. PubMed ID: 32886565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion.
    Liu P; Dong X; Cao X; Xie Q; Huang X; Jiang J; Dai H; Tang Z; Lin Y; Feng S; Luo K
    Microbiol Spectr; 2023 Feb; 11(2):e0451522. PubMed ID: 36749047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.